NASA, the United States space agency, revealed that it was working on a lung ventilator designed especially for patients who contracted COVID-19 and developed by the agency's engineers. It took just over a month for the FDA, the agency that regulates food and drugs in the United States, to grant an emergency use authorization.
A week after the grant from the US regulatory agency, Nasa informs that it has selected eight local companies that will be responsible for manufacturing the ventilators. The space agency will not manufacture the fans, but Caltech, the company that owns the software and product design, has licensed eight companies:
The device designed for NASA is called Ventilator Intervention Technology Accessible Locally (ventilator intervention technology accessible locally, in free translation), and has the suggestive translation of VITAL. Unlike other models, it was manufactured to meet the needs of patients with the new coronavirus.
It has a compact and simple design, and uses only some of the components found in traditional fans, and uses components that suppliers already have in stock, which makes assembly cheaper.
It also has the flexibility to be used even in field hospitals, and this will allow hospitals to store their traditional ventilators for more severe cases of the disease, increasing the chance of patients' survival.